Patents by Inventor Terrence J. Hunt

Terrence J. Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION
    Publication number: 20230256063
    Abstract: Pharmaceutical formulations comprising a clostridial derivative and a permeabilizing agent for intravesical instillation are disclosed.
    Type: Application
    Filed: September 16, 2022
    Publication date: August 17, 2023
    Inventors: Eric A. Forssen, Patrick M. Hughes, David C. Rupp, Terrence J. Hunt, Gary Shimizu, Joseph Francis, Ron S. Broide, Ester Fernandez-Salas, Catherine Rheaume
  • Animal protein-free pharmaceutical compositions
    Patent number: 11524075
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Grant
    Filed: June 28, 2022
    Date of Patent: December 13, 2022
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220370614
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: August 2, 2022
    Publication date: November 24, 2022
    Inventor: Terrence J. Hunt
  • Animal Protein-Free Pharmaceutical Compositions
    Publication number: 20220331429
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 20, 2022
    Inventor: Terrence J. Hunt
  • Animal protein-free pharmaceutical compositions
    Patent number: 11446382
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: September 20, 2022
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • Animal protein-free pharmaceutical compositions
    Patent number: 11285216
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: March 29, 2022
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220031846
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 3, 2022
    Inventor: Terrence J. Hunt
  • ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210346501
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 11, 2021
    Inventor: Terrence J. Hunt
  • ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210322553
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: January 7, 2021
    Publication date: October 21, 2021
    Inventor: Terrence J. Hunt
  • Animal protein-free pharmaceutical compositions
    Patent number: 11147878
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: October 19, 2021
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210268109
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Inventor: Terrence J. Hunt
  • Method for stabilizing a toxin
    Patent number: 11033625
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: June 15, 2021
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • METHOD FOR STABILIZING A TOXIN
    Publication number: 20210038720
    Abstract: Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
    Type: Application
    Filed: October 15, 2020
    Publication date: February 11, 2021
    Inventor: Terrence J. Hunt
  • METHOD TO MANUFACTURE A STABLE PROTEIN
    Publication number: 20200330564
    Abstract: A Clostridial toxin pharmaceutical composition comprising a Clostridial toxin, such as a botulinum toxin, wherein the Clostridial toxin present in the pharmaceutical composition is stabilized by a non-protein excipient such as a polyvinylpyrrolidone, a disaccharide, a trisaccharide, a polysaccharide, an alcohol, a metal, an amino acid, a surfactant and/or a polyethylene glycol.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Inventor: Terrence J. Hunt
  • SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20180271959
    Abstract: A thermo-reversible thermoplastic pharmaceutical composition, comprising a botulinum toxin and a biocompatible poloxamer which provides thermoreversibility to the composition and additionally stabilizes the botulinum toxin, is described. The pharmaceutical composition can be administered to a patient as a liquid, and gels after administration into a sustained release drug delivery system from which the biologically active botulinum toxin is released over a multi-day period thereby localizing the drug as a depot and controlling release to enhance the therapeutic effect per dose.
    Type: Application
    Filed: May 25, 2018
    Publication date: September 27, 2018
    Inventor: Terrence J. Hunt
  • Sustained release poloxamer containing pharmaceutical compositions
    Patent number: 9981022
    Abstract: A thermo-reversible thermoplastic pharmaceutical composition, comprising a botulinum toxin and a biocompatible poloxamer which provides thermoreversibility to the composition and additionally stabilizes the botulinum toxin, is described. The pharmaceutical composition can be administered to a patient as a liquid, and gels after administration into a sustained release drug delivery system from which the biologically active botulinum toxin is released over a multi-day period thereby localizing the drug as a depot and controlling release to enhance the therapeutic effect per dose.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: May 29, 2018
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • BOTULINUM TOXIN COMPOSITIONS
    Publication number: 20170224786
    Abstract: A high potency botulinum toxin pharmaceutical composition comprising two excipients (such as albumin and sodium chloride) in a weight to weight ratio of between about 1 and about 100.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 10, 2017
    Inventor: Terrence J. Hunt
  • Botulinum toxin compositions
    Patent number: 9629904
    Abstract: A high potency botulinum toxin pharmaceutical composition comprising two excipients (such as albumin and sodium chloride) in a weight to weight ratio of between about 1 and about 100.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: April 25, 2017
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt
  • SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160175410
    Abstract: A thermo-reversible thermoplastic pharmaceutical composition, comprising a botulinum toxin and a biocompatible poloxamer which provides thermoreversibility to the composition and additionally stabilizes the botulinum toxin, is described. The pharmaceutical composition can be administered to a patient as a liquid, and gels after administration into a sustained release drug delivery system from which the biologically active botulinum toxin is released over a multi-day period thereby localizing the drug as a depot and controlling release to enhance the therapeutic effect per dose.
    Type: Application
    Filed: March 2, 2016
    Publication date: June 23, 2016
    Inventor: Terrence J. Hunt
  • Pharmaceutical compositions containing botulinum toxin
    Patent number: 9302008
    Abstract: This invention relates to the use of a composition comprising a polysaccharide and a botulinum toxin for reducing a skin wrinkle. In some embodiments, the polysaccharide comprises disaccharides. In some embodiments, the average molecular weight of a disaccharide unit of the polysaccharide is between about 345 D and about 1,000 D.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: April 5, 2016
    Assignee: Allergan, Inc.
    Inventor: Terrence J. Hunt